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Background: Infancy is a period of rapid growth and habit formation and hence could be a critical period for
obesity prevention. Excess weight gain during infancy is associated with later obesity and formula-fed babies are
more likely to gain excess weight compared to breastfed babies. The primary trial outcome is a change in the
weight standard deviation score from birth to 1 year.
Methods/Design: We will recruit 650 to 700 parents who introduce formula-milk feeds within 14 weeks of their
baby's birth to a single (assessor) blind, parallel group, individually randomised controlled trial. The focus of the
intervention is the caregiver (usually the mother), and the focus of the primary outcome is the infant. The
intervention group will receive the behavioural intervention, which aims to reduce formula-milk intake, promote
responsive feeding and healthy weaning, and prevent excessive weight gain during infancy. The intervention is
based on Social Cognitive Theory and action planning (‘implementation intentions’). It consists of three components:
(1) a motivational component to strengthen parents’ motivation to follow the Baby Milk feeding guidelines, (2) an
action planning component to help translate motivation into action, and (3) a coping planning component to help
parents deal with difficult situations. It will be delivered by trained facilitators (research nurses) over 6 months through
three face-to-face contacts, two telephone contacts and written materials. The control group will have the same
number of contacts with facilitators, and general issues about feeding will be discussed. Anthropometric outcomes will
be measured by trained research staff, blind to group allocation, at baseline, 6 months and 12 months following
standard operating procedures. Validated questionnaires will assess milk intake, temperament, appetite, sleep, maternal
quality of life and maternal psychological factors. A 4-day food diary will be completed at 8 months.
Discussion: The results of the trial will help to inform infant feeding guidelines and to understand the links between
infant feeding, behaviour, appetite and growth.
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Childhood obesity has important consequences for mor-
bidity and mortality in childhood and in later life [1]. In
2010, 43 million children under the age of five were obese
or overweight worldwide and the prevalence is predicted
to rise from 6.7 % to 9.1 % in 2020 [2]. In England, data
from the National Child Measurement Programme
(NCMP) show that by the time children start school,
more than one in five are overweight, and one in 10 are
obese [3]. Hence, tackling childhood obesity through
focussing on the early years has become a national pri-
ority [4]. However, to date, there is little evidence on
which to develop effective strategies to prevent child-
hood obesity [5]. A Cochrane Review identified 22 ran-
domised trials to prevent childhood obesity; although
some diet and physical activity interventions were ef-
fective in promoting a healthy diet and increased phys-
ical activity levels, they were not on the whole effective
in preventing weight gain [6]. Only one of the included
studies recruited children below one year of age (average
age 21 months, n = 43), and that was a home-visiting
programme for high-risk Native-American children, fo-
cussing on improving parenting skills to develop appropri-
ate eating and exercise behaviours to prevent obesity [7].
Infancy is a period of rapid growth and could be a crit-
ical time when obesity prevention may be most effective.
Recent systematic reviews have described a consistent as-
sociation between rapid weight gain in infancy and subse-
quent obesity risk in childhood and later life [8–10].
Energy deposition as a percentage of total energy require-
ments decreases from 40 % at 1 month to 1 to 2 % from
12 months until mid-adolescence. Therefore, infancy
weight gain is more closely related to energy intake, than
is weight gain in childhood or in later life. In 2004, based
on new data on energy expenditure in infants, the World
Health Organisation (WHO) reduced the recommended
energy requirements for infants by 15 to 20 % [11].
Current formula-feeding instructions in UK are based on
the previous 1985 WHO recommendations and this may
be an important reason why formula-fed babies are at a
greater risk of rapid weight gain and subsequent obesity
than breastfed infants. Three meta-analyses of observa-
tional studies reported that obesity risk at school age was
reduced by 15–20 % in breastfed compared with formula-
fed infants [12–14]. In 2006, the WHO published growth
charts based on the growth of breastfed babies and rec-
ommends this lower plane of growth as the optimum
standard for growth of all infants [15, 16]. While the
benefits of breastfeeding are well recognised, the 2010
UK Infant Feeding Survey showed that only 21 % of ba-
bies were exclusively breastfed at age 6 weeks and 1 %
at 6 months [17]. Hence in addition to supporting
breastfeeding, it is important to optimise the growth of
formula-fed babies.In the Baby Milk trial we aim to evaluate the efficacy,
cost-effectiveness and acceptability of a theory-based,
multi-component intervention to reduce formula-milk in-
take (based on the 2004 WHO recommendations for en-
ergy requirements) and prevent excess weight gain during
infancy. We also aim to understand the psychological me-
diators of any effect of the intervention on formula-milk
and energy intake.
Methods/Design
Study design
The Baby Milk trial is an explanatory, parallel, individually
randomised controlled trial of parents (mainly mothers)
and their babies who are formula-fed. The focus of the
primary outcome measurement is the baby, but the focus
of the intervention is the caregiver. The intervention will
commence when the baby is enrolled in the study (be-
tween 2 and 14 weeks) and be delivered up to 6 months.
Babies will be followed up to age 1 year. In this explana-
tory trial, the intervention programme will be delivered by
trained and quality-assured facilitators (research nurses).
Participants in the control group will be offered the same
number of contacts and standard advice about formula
feeding, and weaning will be discussed.
Ethical approval has been obtained from the
Cambridgeshire 4 Research Ethics Committee (Ref:10/
H0305/9), and fully informed written consent will be
taken from all participants.
Recruitment and retention
Parents and their babies who are partially or fully formula-
feeding within 14 weeks of birth will be identified by re-
search staff on a postnatal hospital ward; health profes-
sionals, including GPs, midwives and health visitors; and
via a mail-out using the National Health Service (NHS)
database (SystmOne). Most babies in England are delivered
in the hospital and looked after by a community midwife
for the first 2 weeks after discharge from hospital. Subse-
quently, they come under the care of a health visitor who
records if they are formula-feeding in the NHS database.
This database will be used to send a participant informa-
tion sheet to parents in the catchment area. Research staff
and midwives will identify babies within 2 weeks of birth.
General Practices (GP, nurse, and other practice staff) will
invite participants at the baby’s 6-week health check and
immunisation clinics. Parents who return a reply slip ex-
pressing an interest in taking part or finding out more
about the study will be contacted by research staff at the
Medical Research Council (MRC) Epidemiology Unit to
answer any questions, check eligibility criteria, and where
appropriate, invite them for their baseline visit (at 2 to
14 weeks age). GPs and health visitors will be in-
formed by letter if a baby under their care has been
recruited into the study.
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(4 to 6 weekly) contacts with participants in both groups
should reduce attrition. The information sheet will em-
phasise the importance of follow-up irrespective of group
allocation and adherence to the intervention. Participants
who drop out from the intervention will be encouraged to
attend for outcome measurements. For participants who
withdraw from the trial, any data collected up to the with-
drawal date will be retained and safely stored, but contact
details will be removed.
Inclusion and exclusion criteria
All healthy, term infants who are receiving formula-milk
within 14 weeks of birth will be eligible to participate. We
will exclude low birth weight (<2,500 g) and pre-term in-
fants (<37 weeks gestation) and infants with major malfor-
mations, hormonal or metabolic diseases that might
interfere with nutrition or growth. Infants who are onTable 1 Study measures
Measures Baseline 4
Questionnaire measures
Baseline questionnairea I, C
Milk feeds questionnaire I, C I,
Maternal attitudesb I, C
Temperament, sleep and eating behaviourc
4-day diet diaryd
Health Service Utilisation
Maternal quality of lifee I, C
Maternal anxietyf I, C
Intervention evaluation
Anthropometry
Parents’ height I, C
Parents’ weight I, C
Baby weight I, C I
Baby supine length I, C I
Baby head circumference I, C
Baby abdominal circumference I, C
Baby skin fold thickness
Baby abdominal Ultrasound
I Intervention group; C Control group
aBaseline Questionnaire: Parents: Demography (age; education - age at completion
married/single); weight and height. Mother’s: lifestyle (smoking - during pregnancy,
pregnancy and at time of delivery), delivery (normal, instrumental, or caesarean
instructions/appetite/growth - Likert scale). Baby’s: sex, weight and length at bi
bMaternal attitudes and feeding practices (questionnaire developed for use in this s
Theory (self-efficacy, outcome expectancy, intentions, and motivation); perception o
demand/routine/both; feed based on instructions/appetite/growth – Likert scale
Bottle feeds (type, frequency, amounts, duration, how reconstituted, advice followe
Other drinks and foods. Age at weaning (only at 6 months)
cValidated questionnaires used with permission from Prof Jane Wardle and Mary Ro
dDiet diary: developed in collaboration with MRC HNR, and used in the National Die
eQuality of Life: EuroQol Visual Analogue Scale and Short Form 8
fAnxiety: Spiegelberger Short State Anxiety Inventoryspecial formulas (soya-based, lactose-free, hydrolysed or
anti-reflux formulas) at the time of recruitment will also
be excluded; however, they will not be excluded if they are
put on a special formula after randomisation.
Measurements
A summary of the measurements undertaken is pre-
sented in Table 1.
Anthropometry
Anthropometry data will be collected by trained research
assistants using standard operating procedures. In order
to minimise bias, the measurement team will be blind to
group allocation and will be trained to avoid discussing
this with parents. Parents will also be advised not to dis-
cuss allocation with the measurement team.
Weight will be measured with the baby undressed,
using Seca Infant Electronic Scales™ and recorded to themonths 6 months 8 months 12 months
C I, C
I, C
I, C
I, C
I,C I, C
I,C I,C
I,C
I I
I, C I, C
I, C I, C
I, C I, C
I, C I, C
I, C I, C
I, C
I, C
and highest qualification; occupation; ethnicity; marital status - cohabiting/
current alcohol consumption), pregnancy (duration, weight -before
) and previous children (number, feeding-breast, formula, dependent on
rth and 6 weeks
tudy): Mother’s attitudes; psychological measures based on Social Cognitive
f baby’s weight. Type of feed (breast/ expressed/ formula/ mixed), feed on
d, age when started), Breastfeeds (frequency, duration, and expressed milk).
thbart
t and Nutrition Survey of Infants and Young Children
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a Kiddimeter™ or Starters mat™, with only the nappy on
and measured to the nearest 0.5 cm. Abdominal waist
circumference will be measured using a D-loop non-
stretch fibreglass tape measure and head circumference
will be measured using the Child Growth Foundation
reusable tape. Sub-scapular, triceps, quadriceps and
flank skin fold thickness will be measured using the
Holtain Tanner™/Whitehouse™ skin fold calliper with an
average of three measurements taken for each site. A
standard ultrasound device with a 3C-RS curved trans-
ducer will be used to measure intra-abdominal depth
and subcutaneous fat.
Parents’ weight and percentage body fat will be mea-
sured on a Tanita™ scale and height with a Seca™ wall-
mounted stadiometer.
Questionnaires
A baseline questionnaire will be used to collect data from
parents about demography (age, education, occupation,
ethnicity, marital status), lifestyle (smoking, alcohol con-
sumption, BMI), pregnancy (duration, weight gain), deliv-
ery and previous children (number, feeding).
We have developed and validated a questionnaire to as-
sess milk feeding practices and hypothesised psychological
mediators of any intervention effect informed by Social
Cognitive Theory: attitudes, self-efficacy, outcome-
expectancies and intentions with regard to following
feeding recommendation (feeding and growth question-
naire) [18]. Baby eating behaviour, sleep and tempera-
ment have recently been studied as potential risk
factors for obesity [19–21]. We will use a combination
of questionnaires developed by other groups (Mary
Rothbart and Jane Wardle) to assess these. The tem-
perament questionnaire has been validated for use in
infants [22] and the eating behaviour questionnaire has
been validated in older children [23, 24].
A 4-day diet diary will be used to assess energy intake
at 8 months. The diary will be the same as that used by
the MRC Human Nutrition Research Unit (MRC HNR)
for the National Diet and Nutrition Survey of Infants
and Young Children (DNSIYC). Dietary data will be ana-
lysed using the Diet in Nutrients Out (DINO) computer
package [25] by the dietary assessment team at the MRC
HNR, who will not be aware of group allocation.
Parent’s quality of life will be assessed using the EuroQoL
Visual Analogue Scale (VAS) and Standard Form (SF) 8. A
questionnaire to measure health service utilisation (hos-
pital, primary and community care use) using standard
questions will be administered at 6 and 12 months. Par-
ents’ perceptions of the usefulness of the different compo-
nents of the intervention (face-to-face and telephone
contacts, leaflets, stickers) will be assessed among interven-
tion group participants.The questionnaires will be self-administered prior to
the visit with an opportunity to clarify any doubts during
the visit.
Randomisation and consent
Only participants who attend for the baseline visit will be
randomised to intervention or control groups in order to
minimise the bias from selective drop out. Central tele-
phone randomisation will be conducted based on a random
number table (generated by an independent statistician)
linked to the study database. We expect that important co-
variates (such as birth weight, sex, gestational age, family
size, maternal BMI, smoking, ethnicity, educational level,
age at entry into the study and whether predominantly
formula-fed) will be balanced between groups due to the
large sample size. Written informed consent will be ob-
tained at baseline visit by a trained research assistant con-
ducting measurements.
Intervention group
The MRC guidance for complex interventions was used
to design the intervention [26]. This was an iterative
process including a review of relevant theory to under-
pin the intervention; systematic reviews of parents’ ex-
periences of bottle feeding [27] and determinants of
non-recommended feeding practices [28]; and involve-
ment of mothers, psychologists, doctors, midwives and
health visitors [29]. The motivational component of the
intervention is based on Bandura’s Social-Cognitive The-
ory (SCT), which has shown utility for understanding and
changing dietary behaviours [30–32]. In order to help par-
ticipants to translate their motivation into action, partici-
pants are encouraged to set goals and to formulate action
plans, based on the concept of ‘implementation inten-
tions’ [33–35]. They are also encouraged to monitor on a
feeding-plan how much they are feeding their baby against
Baby Milk intervention guideline amounts. Finally, partici-
pants are encouraged to keep on track by formulating
coping plans (that is, problem solving), which are ‘if-then’
plans specifying how they will deal with difficult situa-
tions, such as the baby crying. In summary, the intervention
consists of three components: a motivational component,
an action planning component to help translate motivation
into action (including goal setting, action plans and self-
monitoring), and a coping planning component helping
parents to deal with difficult situations.
The intervention will be delivered by trained facilitators
(research nurses) from the baby’s enrolment in the trial (2
to 14 weeks old) to 6 months and will consist of three
face-to-face sessions and two telephone contacts in
addition to two leaflets based on SCT (Fig. 1). The face-
to-face sessions will last approximately 30 to 45 min and
the telephone contacts 15 to 20 min. Since social support
is important, both parents will be encouraged to attend
Mothers who start formula-feeds within twelve weeks of baby’s birth will be 
invited to participate
Baby’s age 2 to 14 weeks
Baseline measurements and questionnaires (n = 700)
Intervention Group
(n = 350) 1st Face-to-face, leaflet, 
stickers, feeding plan
Control Group
(n = 350) 1st Face-to-face, standard 
bottle-feeding Leaflet
4 to 6 weeks later 1st Telephone contact
4 to 5 months 2nd Face-to-face 4 to 5 months Telephone contact
8 months Food Diary
12 months Follow-up measurements and questionnaires
5 to 6 months Telephone contact5 to 6 months 2nd Telephone
6 to 7 months 2nd Face-to-face. 
Follow up measurements and 
6 to 7 months 3rd Face-to-face. 
Follow up measurements and 
Fig. 1 Trial Flow Chart
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cilitator will talk parents through the ‘healthy infant
growth and nutrition’ leaflet that explains the new feeding
recommendations (Table 2) and the growth charts. The
leaflet does not just impart knowledge about amounts of
formula-feeds, hunger cues, growth charts and rapid
weight gain, but also aims to encourage recommended
feeding behaviours by strengthening self-efficacy and per-
ceived benefits about following the recommendations.
Demonstration of correct feed preparation (if required)
and explanation of the feeding recommendations will be
provided. Parents will be encouraged to make a feeding
plan and provided with stickers to put on the formula
milk packets. When the baby is 4-months old, parents will
be invited for a second session and advice on weaning and
feedback on baby’s growth will be provided. Two phone-
calls - when the baby is age 2 to 3 months and 5 months -will be made to monitor progress with following recom-
mendations and to support the parents with ongoing goal
setting, action planning, self-monitoring and problem-
solving. At the 6-month visit, the baby’s growth will be
plotted on the WHO growth charts. Facilitators will feed
back this information to parents, and they will be encour-
aged to monitor the growth of their babies also after the
end of the intervention delivery at 6 months. Growth
monitoring is important because parents are not very
good at identifying obesity in their children [36], so
any programme to prevent obesity must include early
identification.
Control group
The control group will be offered the same number of con-
tacts with facilitators (attention control) and general infor-
mation about formula-feeding (bottles, teats, sterilisation,
Table 2 Comparison between the guidelines on a standard formula milk packet and Baby Milk intervention guidelines
SMA guidelines Intervention guidelines
Age Weight scoops/day kJ/kg/day scoops/day kJ/kg/day % Reduction
Birth 3.5 kg 18 496 18 496 0
2 wks 3.9 kg 24 590 18 442 25
1 mo 4.4 kg 24 525 21 459 13
2 mo 5.3 kg 25 454 22 399 12
3 mo 6.1 kg 25 393 22 346 12
4 mo 6.8 kg 35 494 30 423 14
6 mo 7.8 kg 32 390 28 341 13
Based on SMA™ white: 4.4 g/scoop; 2,173 kJ per 100 g powder
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phone calls will be used to discuss general issues (parent-
ing, sleep, etcetera), to monitor feed quantity and frequency
and to encourage continued participation in the study.
Parents in both groups will be given a help-line num-
ber to contact the study team about feeding issues.
Training in intervention delivery and intervention fidelity
Facilitator training includes a 2-day training programme
in the evidence base underlying the intervention, theor-
ies, behaviour change techniques, intervention strategies
and communication skills, including demonstration and
practice with individual feedback. The training is sup-
ported by an extensive training manual. In order to
standardise intervention delivery, facilitators will use
standardised protocols for all the contacts in the inter-
vention and control conditions. Four research nurses
will deliver the intervention and control group protocols
and all face-to-face and telephone consultations will be
audio-taped. Fidelity will be promoted, and contamin-
ation across the two groups minimised by assessing a
random sample of audio-taped contacts using standar-
dised fidelity checklists, peer appraisal, followed by feed-
back and team discussion. Team meetings will be held
over the whole period of intervention delivery to discuss
and problem solve challenging situations.
Sample size calculation
The primary outcome is conditional infant weight gain
from birth to 12 months of age (conditional on birth
weight). Birth weight and weight at 6 and 12 months will
be converted to standard deviation scores (SDS) adjusted
for age and sex using the WHO 2006 growth standard.
SDS refers to the number of standard deviations the
measurement lies above (positive value) or below (nega-
tive value) the 50th percentile (median value 0). Condi-
tional weight gain is calculated as the change in weight
SDS between birth to age 12 months, adjusted for birth
weight SDS.
In the Avon Longitudinal Study of Parents and Children
(ALSPAC), among 518 formula and mixed-fed infants,mean ± SD for conditional weight gain was 0.65 ± 0.87,
and for energy intake at 4 months was 2768 ± 479 kJ/day.
Based on those data, we estimated that our target 15 %
(420 kJ/day) reduction in energy intake would lead to a
(mean ± SE) 0.16 ± 0.04 lower gain in weight SDS between
0 to 8 months [37]. We have powered the study on a more
conservative estimate of a 10 % to 11 % achieved reduc-
tion in energy intake, which corresponds to a difference in
weight SDS of 0.11 to 0.12. However, the estimated effect
size should be corrected for regression dilution because
energy intake in ALSPAC was estimated from unweighed
1-day diet diaries. Lanigan et al. reported the within-
(778 kJ) and between-infant (824 kJ) SD during the 5-day
diet diaries in the 6- to 24-month-old infants, and this
gives a regression dilution correction factor of 1.89 [38].
With a 10 % to 11 % lower calorie intake in the interven-
tion group, we can expect a 0.20 to 0.21 SDS (0.11 to
0.12*1.89) difference between the two groups.
Sample sizes of 250 to 290 infants in each group will
provide 80 % power at the two sided 5 % level to detect
a 0.20 to 0.21 SDS difference in weight gain between the
intervention and the control group. Allowing for around
15 % loss to follow-up, we aim to recruit 300 to 350 in-
fants to each group.
Data analysis
All quantitative data will be double-entered by an experi-
enced, independent data entry company with whom the
MRC Epidemiology Unit has an established agreement.
Statistical analysis will be performed using STATA™ statis-
tical software. All qualitative data will be transcribed
verbatim and analysed using Microsoft Excel™ or the
Framework™ software.
Important baseline characteristics of participants in
the two groups will be described. The main analyses
will compare the intervention and control groups by
‘intention-to-treat’. A secondary ‘per protocol’ analysis
will be undertaken among those completing the inter-
vention programme based on attendance at 4/5 sessions
(80 % attendance). Comparisons will adjust for age, sex,
birth weight, age when formula-milk was started, and
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differ between babies who are fully formula-fed and
those who are mixed fed (breast and bottle), provided
there are sufficient babies in the two groups, sub-group
analysis for the primary outcome will be calculated
within each of the two feeding practice subgroups. In
addition to the primary outcome of change in weight
SDS from birth to 12 months, there are a number of
secondary outcomes.
Growth
Weight, length and BMI will be converted to SDS ad-
justed for age and sex using the British 1990 growth ref-
erence and the WHO 2006 growth standard at different
time points (birth, baseline, six and 12 months). Babies
in the intervention and control groups will be compared
for change in weight, length and BMI SDS from birth
and baseline to 6 and 12 months. Percentage of babies
crossing the 1 percentile band (0.67 SDS) in the two
groups will be compared. Their abdominal circumfer-
ence, sub-cutaneous and intra-abdominal fat (skin-fold
thickness and ultrasound measurements) will also be
compared at 1 year.
Dietary intake
Differences in milk intake between intervention and con-
trol groups at 2, 3, 4, 5 and 6 months and age at introduc-
tion of solids will be compared using questionnaire data.
Energy intake from 4-day diet diary data will be compared
at 8 months.
Temperament, sleep, and eating behaviour
Between-group differences would be useful to study me-
diation or moderation of effect and to assess any adverse
effects of our intervention on temperament and sleep.
Psychological mediators of infant-feeding behaviours
Differences in maternal attitudes, beliefs, intentions, self-
efficacy, and outcome expectancies will be assessed
between intervention and control groups. Mediation
analyses will be conducted to examine to what extent any
effect of the intervention on infant feeding behaviours is
fully or partially explained by the above beliefs.
Parents’ anthropometry
A useful halo-effect of our intervention would be if due to
increased awareness, parents lost weight. At 12 months,
we will compare parents’ BMI between intervention and
control groups, adjusted for baseline measures.
Acceptability
Parents’ satisfaction with different aspects of the inter-
vention will be assessed at 6 months using a question-
naire. Semi-structured interviews in a sub-sample ofintervention and control group participants and all facil-
itators will explore how feeding decisions were made, to
explain any intervention effects, identify which compo-
nents were acceptable and potentially effective, how
participants responded to the intervention or control
contacts, any contextual factors that influenced partici-
pant responses, and barriers and facilitators of inter-
vention delivery as perceived.
Costs, health service utilisation, and economic analysis
We developed instruments to collect facilitator time spent
in delivering the intervention and infant primary and sec-
ondary health service utilisation. The total cost of the
intervention from the perspective of the NHS will be de-
termined by multiplying these quantities by nationally rep-
resentative unit costs. The economic evaluation will
comprise a cost-consequences analysis to show the cost of
delivering the intervention plus infant health service costs
and outcomes (proportion of infants whose weight crosses
more than one centile band upwards on the growth charts
(0.67 SDS), infants of normal weight at 12 months, and
probability of being normal weight as an adult using data
from a meta-analysis [39]), for intervention and control
groups. Where appropriate, incremental cost-effectiveness
ratios will also be calculated, and uncertainty presented as
95 % confidence intervals around incremental costs and
outcomes, and cost-effectiveness acceptability curves.
Confidentiality
All information that is collected will be kept strictly
confidential and stored anonymously, using a study identi-
fication (ID) number, by the MRC Epidemiology Unit,
University of Cambridge and its collaborators, which in-
cludes the University of East Anglia. Codes connecting in-
dividual identity to the stored data records will be kept
separately. The database containing personal information
will be stored on a password and firewall protected secure
standalone server, in the MRC Epidemiology Unit, Univer-
sity of Cambridge.
Assessment of safety
As the aim of the intervention is to realign the growth
of formula-fed infants more closely to that of breastfed
infants, we consider that the risks to the babies (and par-
ents) will be negligible. However we will actively elicit
and record any (seemingly related or unrelated) adverse
events and report/take action as appropriate.
Eliciting adverse events
Baby weight measurements might reveal underweight
(weight <0.4th centile) or weight faltering (crossing down
through ≥2 weight centile lines). We will also ask at each
visit whether the baby has had any unplanned contacts
with a health professional (that is, other than routine
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giver if they have any health concerns about the baby. A
potential unintended consequence of the Baby Milk
intervention could be increased anxiety for the par-
ent(s). Changes in anxiety levels will be assessed using
the EuroQoL Visual Analogue Scale (VAS), completed
by the primary caregiver (usually the mother) at base-
line and 6-month visits. A drop in score of >30 points
at 6 months will initiate a follow-up phone call by the
study team.Reporting adverse events
All adverse events will be recorded in the case report
form, and depending on the severity and likely causality,
will be reported to the Sponsor/Ethics Committee ac-
cording to good clinical practice (GCP) guidelines. Inci-
dental findings of underweight or weight faltering (as
defined above) will be reviewed by our clinically trained
investigators (paediatricians) and reported to the baby’s
GP together with advice on management. In the first in-
stance, in the absence of other symptoms, this will usu-
ally be more frequent monitoring of weight by the
Health Visitor or GP. All other incidental findings will
be discussed with clinically trained investigators who will
decide whether further assessment and/or reporting to
the baby’s GP, and continued participation in the trial
are indicated.Discussion
This will be the first trial to evaluate the effectiveness
and cost-effectiveness of a theory-based intervention to
reduce formula-milk intake (based on the 2004 WHO
recommendations for energy requirements) and prevent
excess weight gain during infancy. Since 80 % of babies
in England receive some formula feeds by 6 weeks of age
[17], if effective, the intervention has the potential to
make a significant contribution to reducing the burden
of childhood obesity.
Despite the high prevalence of obesity at school entry,
most prevention efforts have focussed on school-aged
children and adolescents and have met with limited
success [6]. Obesity prevention trials in infancy are a
recent area of research because infancy is a period of
rapid growth, habit formation and developmental plas-
ticity. A 2015 systematic review of interventions deliv-
ered antenatally or within the first 2 years of life
identified 27 RCTs. The 24 behavioural trials mainly fo-
cused on breastfeeding promotion, responsive feeding
and parenting/maternal health while the three non-
behavioural trials altered the composition of formula-milk
[40]. Although these trials were designed to prevent child-
hood obesity, none of them specifically targeted formula-
milk intake and the interventions differ markedly in theirhypotheses, interventions they evaluated, design and exe-
cution from the Baby Milk trial.
Regardless of its efficacy in reducing energy intake and
excess weight gain during infancy, the Baby Milk trial will
enhance understanding of participant and contextual fac-
tors that influence excess infant feeding, an area that is
currently under-researched. The results of this study will
also be informative to the Scientific Advisory Committee
on Nutrition (SACN) and Department of Health with re-
gard to the future adoption of the revised WHO guide-
lines in the UK.
Trial status
The trial was recruiting at the time of submission.
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